Evaluation of a recombinant human gelatin as a substitute for a hydrolyzed porcine gelatin in a refrigerator-stable Oka/Merck live varicella vaccine.

Liska V, Bigert SA, Bennett PS, Olsen D, Chang R, Burke CJ.

J Immune Based Ther Vaccines. 2007 Feb 23;5:4.

PMID: 17319952 [PubMed]

Related Articles Free article in PMC

Restriction fragment differences between the genomes of the Oka varicella vaccine virus and American wild-type varicella-zoster virus.

Adams SG, Dohner DE, Gelb LD.

J Med Virol. 1989 Sep;29(1):38-45.

PMID: 2573686 [PubMed - indexed for MEDLINE]

Related Articles

Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial.

Trannoy E, Berger R, Holländer G, Bailleux F, Heimendinger P, Vuillier D, Creusvaux H.

Vaccine. 2000 Feb 25;18(16):1700-6.

PMID: 10689152 [PubMed - indexed for MEDLINE]

Related Articles

Construction of Oka varicella vaccine expressing human immunodeficiency virus env antigen.

Shiraki K, Sato H, Yoshida Y, Yamamura JI, Tsurita M, Kurokawa M, Kageyama S.

J Med Virol. 2001 Jun;64(2):89-95.

PMID: 11360239 [PubMed - indexed for MEDLINE]

Related Articles

Complete DNA sequences of two oka strain varicella-zoster virus genomes.

Tillieux SL, Halsey WS, Thomas ES, Voycik JJ, Sathe GM, Vassilev V.

J Virol. 2008 Nov;82(22):11023-44. Epub 2008 Sep 10.

PMID: 18787000 [PubMed - indexed for MEDLINE]

Related Articles

A dose-response study of a live attenuated varicella-zoster virus (Oka strain) vaccine administered to adults 55 years of age and older.

Berger R, Trannoy E, Holländer G, Bailleux F, Rudin C, Creusvaux H.

J Infect Dis. 1998 Nov;178 Suppl 1:S99-103.

PMID: 9852985 [PubMed - indexed for MEDLINE]

Related Articles

Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model.

Zerboni L, Hinchliffe S, Sommer MH, Ito H, Besser J, Stamatis S, Cheng J, Distefano D, Kraiouchkine N, Shaw A, Arvin AM.

Virology. 2005 Feb 5;332(1):337-46.

PMID: 15661165 [PubMed - indexed for MEDLINE]

Related Articles

Immunogenicity of Oka/Merck varicella vaccine in children vaccinated at 12-14 months of age versus 15-23 months of age.

Silber JL, Chan IS, Wang WW, Matthews H, Kuter BJ.

Pediatr Infect Dis J. 2007 Jul;26(7):572-6.

PMID: 17596796 [PubMed - indexed for MEDLINE]

Related Articles

New method of differentiating wild-type varicella-zoster virus (VZV) strains from Oka varicella vaccine strain by VZV ORF 6-based PCR and restriction fragment length polymorphism analysis.

Takayama M, Takayama N.

J Clin Virol. 2004 Feb;29(2):113-9.

PMID: 14747030 [PubMed - indexed for MEDLINE]

Related Articles

Development of immunogenic recombinant Oka varicella vaccine expressing hepatitis B virus surface antigen.

Shiraki K, Hayakawa Y, Mori H, Namazue J, Takamizawa A, Yoshida I, Yamanishi K, Takahashi M.

J Gen Virol. 1991 Jun;72 ( Pt 6):1393-9.

PMID: 1646279 [PubMed - indexed for MEDLINE]

Related Articles

Zoster vaccine live (Oka/Merck).

Robinson DM, Perry CM.

Drugs Aging. 2006;23(6):525-31; discussion 532-3. Review.

PMID: 16872235 [PubMed - indexed for MEDLINE]

Related Articles

Infection of human fetal dorsal root neurons with wild type varicella virus and the Oka strain varicella vaccine.

Somekh E, Levin MJ.

J Med Virol. 1993 Jul;40(3):241-3.

PMID: 8394874 [PubMed - indexed for MEDLINE]

Related Articles

Comparison of gpELISA and neutralizing antibody responses to Oka/Merck live varicella vaccine (Varivax) in children and adults.

Krah DL, Cho I, Schofield T, Ellis RW.

Vaccine. 1997 Jan;15(1):61-4.

PMID: 9041667 [PubMed - indexed for MEDLINE]

Related Articles

A varicella vaccine stable at 5 degrees C.

Fanget B, Françon A.

Dev Biol Stand. 1996;87:167-71.

PMID: 8854014 [PubMed - indexed for MEDLINE]

Related Articles

Comparison between of the attenuated BR-Oka and the wild type strain of Varicella Zoster Virus (VZV) on the DNA level.

Lim SM, Song SW, Kim SL, Jang YJ, Kim KH, Kim HJ.

Arch Pharm Res. 2000 Aug;23(4):418-23.

PMID: 10976594 [PubMed - indexed for MEDLINE]

Related Articles

Detection and genotyping of varicella-zoster virus by TaqMan allelic discrimination real-time PCR.

Campsall PA, Au NH, Prendiville JS, Speert DP, Tan R, Thomas EE.

J Clin Microbiol. 2004 Apr;42(4):1409-13.

PMID: 15070981 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Comparison of virus transcription during lytic infection of the Oka parental and vaccine strains of Varicella-Zoster virus.

Cohrs RJ, Gilden DH, Gomi Y, Yamanishi K, Cohen JI.

J Virol. 2006 Mar;80(5):2076-82.

PMID: 16474115 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

The effect of decreasing amounts of live virus, while antigen content remains constant, on immunogenicity of Oka/Merck varicella vaccine.

Watson B, Piercy S, Soppas D, Browngoehl K, Warner M, Isganitis K, White CJ, Kuter B, Chua J, Starr S.

J Infect Dis. 1993 Dec;168(6):1356-60.

PMID: 8245520 [PubMed - indexed for MEDLINE]

Related Articles

Varicella-zoster virus isolates, but not the vaccine strain OKA, induce sensitivity to alpha-1 and beta-1 adrenergic stimulation of sensory neurones in culture.

Schmidt M, Kress M, Heinemann S, Fickenscher H.

J Med Virol. 2003;70 Suppl 1:S82-9.

PMID: 12627494 [PubMed - indexed for MEDLINE]

Related Articles

Molecular diagnosis of zoster post varicella vaccination.

Sauerbrei A, Uebe B, Wutzler P.

J Clin Virol. 2003 Jul;27(2):190-9.

PMID: 12829041 [PubMed - indexed for MEDLINE]

Related Articles